Literature DB >> 8694729

Endophthalmitis after filtering surgery with mitomycin.

D S Greenfield1, I J Suñer, M P Miller, T A Kangas, P F Palmberg, H W Flynn.   

Abstract

OBJECTIVE: To identify the incidence, causative organisms, and clinical outcomes of eyes with bleb-associated endophthalmitis after glaucoma filtering procedures with adjunctive mitomycin.
METHODS: Retrospective analysis of 773 consecutive eyes that underwent glaucoma filtering surgery at the Bascom Palmer Eye Institute, Miami, Fla. The course of 609 eyes from 485 patients with a minimum of 3 months of follow-up were reviewed.
RESULTS: Mean follow-up was 16.0 +/- 11.5 months (range, 3-48 months). Of the 609 eyes, 13 (2.1%) developed bleb-associated endophthalmitis an average of 18.5 +/- 13.2 months after surgery (range, 1-45 months). The incidence of bleb-associated endophthalmitis was significantly greater after inferior trabeculectomy (7.8% per patient-year) than after superior trabeculectomy (1.3% per patient-year) by Kaplan-Meier estimates (P = .02, log rank test). The cumulative incidence was 13% for inferior limbal blebs and 1.6% for superior limbal blebs. Nine (69.2%) of the 13 eyes were culture positive. Streptococcus sanguis and Haemophilus influenzae (6/13 [46.2%]) were the most frequent causative organisms. The mean increase in intraocular pressure after endophthalmitis treatment was 1.2 mm Hg, with a mean decrease in visual acuity of 1.42 logMAR units. Eight (61.5%) of the 13 eyes had a final acuity of 20/400 or better.
CONCLUSIONS: The incidence of bleb-associated endophthalmitis after guarded filtering surgery performed with adjunctive mitomycin is higher than the reported rate in eyes undergoing filtering surgery without the use of antifibrotic agents (0.2%-1.5%). Inferior limbal trabeculectomy carries the highest risk of infection. Eyes with mitomycin blebs maintained excellent filtration capacity. However, after treatment of the infection, the visual outcomes were generally poor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694729     DOI: 10.1001/archopht.1996.01100140151007

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  72 in total

1.  Should we vaccinate for glaucoma surgery?

Authors:  R R Seemongal-Dass; T E James
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Risk factors for development of post-trabeculectomy endophthalmitis.

Authors:  O J Lehmann; C Bunce; M M Matheson; V Maurino; P T Khaw; R Wormald; K Barton
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

3.  Posttrabeculectomy endophthalmitis caused by Moraxella nonliquefaciens.

Authors:  Helene Laukeland; Kåre Bergh; Lars Bevanger
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

4.  Prevalence of open-angle glaucoma among adults in the United States.

Authors:  David S Friedman; Roger C W Wolfs; Benita J O'Colmain; Barbara E Klein; Hugh R Taylor; Shelia West; M Cristina Leske; Paul Mitchell; Nathan Congdon; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

5.  The safety and efficacy of combined phacoemulsification and trabeculectomy with releasable sutures.

Authors:  W J Stark; R K Goyal; O Awad; E Vito; A C Kouzis
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

6.  A review of canaloplasty.

Authors:  Ben J Harvey; Mahmoud A Khaimi
Journal:  Saudi J Ophthalmol       Date:  2011-08-16

7.  Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK.

Authors:  A Gupta; H O Orlans; S J Hornby; I C J W Bowler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-11       Impact factor: 3.117

8.  Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).

Authors:  Preston Howard Blomquist
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  Recurrent bleb infections.

Authors:  S Waheed; J M Liebmann; D S Greenfield; D C Ritterband; J A Seedor; M Shah; R Ritch
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

10.  Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS).

Authors:  Sarwar Zahid; David C Musch; Leslie M Niziol; Paul R Lichter
Journal:  Am J Ophthalmol       Date:  2012-12-13       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.